PROGRESSION OF A FOCAL ISCHEMIC LESION IN RAT-BRAIN DURING TREATMENT WITH A NOVEL GLYCINE NMDA ANTAGONIST - AN IN-VIVO 3-DIMENSIONAL DIFFUSION-WEIGHTED MR MICROSCOPY STUDY/

Citation
H. Qiu et al., PROGRESSION OF A FOCAL ISCHEMIC LESION IN RAT-BRAIN DURING TREATMENT WITH A NOVEL GLYCINE NMDA ANTAGONIST - AN IN-VIVO 3-DIMENSIONAL DIFFUSION-WEIGHTED MR MICROSCOPY STUDY/, Journal of magnetic resonance imaging, 7(4), 1997, pp. 739-744
Citations number
43
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
ISSN journal
10531807
Volume
7
Issue
4
Year of publication
1997
Pages
739 - 744
Database
ISI
SICI code
1053-1807(1997)7:4<739:POAFIL>2.0.ZU;2-I
Abstract
Stroke was induced in two groups of anesthetized rats by occlusion of the middle cerebral artery (MCA) and ipsilateral common carotid artery . Group 1 (control) received vehicle and group 2 received the glycine N-methyl-D-aspartate (NMDA) antagonist ZD9379. Stroke volume was asses sed by three-dimensional diffusion-weighted MR microscopy at 2.5 and 6 hours of MCA occlusion, At 2.5 hours, stroke volumes were identical i n the two groups. At 6 hours, stroke volumes had increased by 15% in t he control group; in contrast, the treated group showed a 40% reduced stroke volume, Conclusions from this in vivo study were as follows: (a ) our technique allows more efficient and accurate measurement of stro ke volume with an improvement in resolution over a previous method; (b ) the ability to measure stroke volume at multiple time points shows v olume change and assessment of time dependency of drug treatment; (c) at 6 hours, the glycine antagonist ZD9379 reduced stroke volume by 40% .